These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 18073170)
41. The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit. Cox RA; Rao P; Brandon-Cox C J Hosp Infect; 2001 Jul; 48(3):186-92. PubMed ID: 11439005 [TBL] [Abstract][Full Text] [Related]
42. Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions. Binns E; Tuckerman J; Licciardi PV; Wurzel D J Paediatr Child Health; 2022 Oct; 58(10):1741-1746. PubMed ID: 36073299 [TBL] [Abstract][Full Text] [Related]
43. Impact of wheezing after respiratory syncytial virus infection on health-related quality of life. Bont L; Steijn M; van Aalderen WM; Kimpen JL Pediatr Infect Dis J; 2004 May; 23(5):414-7. PubMed ID: 15131463 [TBL] [Abstract][Full Text] [Related]
48. Virus-induced airway dysfunction: pathogenesis and biomechanisms. Dakhama A; Lee YM; Gelfand EW Pediatr Infect Dis J; 2005 Nov; 24(11 Suppl):S159-69, discussion S166-7. PubMed ID: 16378041 [TBL] [Abstract][Full Text] [Related]
49. Apnea with RSV infection in three infants receiving palivizumab. Del Vecchio MT Pediatr Int; 2013 Dec; 55(6):e159-61. PubMed ID: 24330303 [TBL] [Abstract][Full Text] [Related]
50. Eosinophil cationic protein in infants with respiratory syncytial virus bronchiolitis: predictive value for subsequent development of persistent wheezing. Pifferi M; Ragazzo V; Caramella D; Baldini G Pediatr Pulmonol; 2001 Jun; 31(6):419-24. PubMed ID: 11389573 [TBL] [Abstract][Full Text] [Related]
51. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. Robinson KA; Odelola OA; Saldanha I; McKoy N Cochrane Database Syst Rev; 2010 Feb; (2):CD007743. PubMed ID: 20166098 [TBL] [Abstract][Full Text] [Related]
52. Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children. Singleton RJ; Redding GJ; Lewis TC; Martinez P; Bulkow L; Morray B; Peters H; Gove J; Jones C; Stamey D; Talkington DF; DeMain J; Bernert JT; Butler JC Pediatrics; 2003 Aug; 112(2):285-90. PubMed ID: 12897275 [TBL] [Abstract][Full Text] [Related]
53. Palivizumab outcomes registry data from Spain: Infección Respiratoria Infantil por Virus Respiratorio Sincitial (IRIS) Study Group. Carbonell-Estrany X Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S55-7; discussion S57. PubMed ID: 12671453 [TBL] [Abstract][Full Text] [Related]
54. Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis. Lofland JH; O'Connor JP; Chatterton ML; Moxey ED; Paddock LE; Nash DB; Desai SA Clin Ther; 2000 Nov; 22(11):1357-69. PubMed ID: 11117660 [TBL] [Abstract][Full Text] [Related]
55. Current strategies in the prevention of respiratory syncytial virus disease. Paes BA Paediatr Respir Rev; 2003 Mar; 4(1):21-7. PubMed ID: 12615029 [TBL] [Abstract][Full Text] [Related]
56. Indications to respiratory syncytial virus immunoprophylaxis in the 29-32 wGA group: is there still room for debating? Zuccotti G; Fabiano V Ital J Pediatr; 2017 Feb; 43(1):17. PubMed ID: 28257653 [TBL] [Abstract][Full Text] [Related]
57. Respiratory syncytial virus infection and chronic respiratory morbidity - is there a functional or genetic predisposition? Drysdale SB; Milner AD; Greenough A Acta Paediatr; 2012 Nov; 101(11):1114-20. PubMed ID: 22963586 [TBL] [Abstract][Full Text] [Related]
58. Rhinovirus-associated wheezing in infancy: comparison with respiratory syncytial virus bronchiolitis. Korppi M; Kotaniemi-Syrjänen A; Waris M; Vainionpää R; Reijonen TM Pediatr Infect Dis J; 2004 Nov; 23(11):995-9. PubMed ID: 15545853 [TBL] [Abstract][Full Text] [Related]
59. Risk factors for recurrent wheezing in preterm infants who received prophylaxis with palivizumab. Manini MB; Matsunaga NY; Gianfrancesco L; Oliveira MS; Carvalho MRV; Ribeiro GLMT; Morais EO; Ribeiro MAGO; Morcillo AM; Ribeiro JD; Toro AADC J Bras Pneumol; 2021; 47(5):e20210157. PubMed ID: 34669834 [TBL] [Abstract][Full Text] [Related]
60. Palivizumab: a review of its use as prophylaxis for serious respiratory syncytial virus infection. Fenton C; Scott LJ; Plosker GL Paediatr Drugs; 2004; 6(3):177-97. PubMed ID: 15170364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]